ID   PP2AA_RAT               Reviewed;         309 AA.
AC   P63331; O88591; P13353;
DT   11-OCT-2004, integrated into UniProtKB/Swiss-Prot.
DT   11-OCT-2004, sequence version 1.
DT   02-OCT-2024, entry version 165.
DE   RecName: Full=Serine/threonine-protein phosphatase 2A catalytic subunit alpha isoform;
DE            Short=PP2A-alpha;
DE            EC=3.1.3.16 {ECO:0000250|UniProtKB:P67775};
GN   Name=Ppp2ca;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Heart;
RX   PubMed=2554255; DOI=10.1093/nar/17.20.8369;
RA   Posas F., Arino J.;
RT   "Nucleotide sequence of a rat heart cDNA encoding the isotype alpha of the
RT   catalytic subunit of protein phosphatase 2A.";
RL   Nucleic Acids Res. 17:8369-8369(1989).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Liver;
RX   PubMed=2461222; DOI=10.1016/0167-4781(88)90032-2;
RA   Kitagawa Y., Tahira T., Ikeda I., Kikuchi K., Tsuiki S., Sugimura T.,
RA   Nagao M.;
RT   "Molecular cloning of cDNA for the catalytic subunit of rat liver type 2A
RT   protein phosphatase, and detection of high levels of expression of the gene
RT   in normal and cancer cells.";
RL   Biochim. Biophys. Acta 951:123-129(1988).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Heart, and Lung;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
CC   -!- FUNCTION: Catalytic subunit of protein phosphatase 2A (PP2A), a
CC       serine/threonine phosphatase involved in the regulation of a wide
CC       variety of enzymes, signal transduction pathways, and cellular events.
CC       PP2A is the major phosphatase for microtubule-associated proteins
CC       (MAPs). PP2A can modulate the activity of phosphorylase B kinase casein
CC       kinase 2, mitogen-stimulated S6 kinase, and MAP-2 kinase (By
CC       similarity). Cooperates with SGO2 to protect centromeric cohesin from
CC       separase-mediated cleavage in oocytes specifically during meiosis I (By
CC       similarity). Can dephosphorylate SV40 large T antigen and p53/TP53.
CC       Activates RAF1 by dephosphorylating it at 'Ser-259'. Mediates
CC       dephosphorylation of WEE1, preventing its ubiquitin-mediated
CC       proteolysis, increasing WEE1 protein levels, and promoting the G2/M
CC       checkpoint. Mediates dephosphorylation of MYC; promoting its ubiquitin-
CC       mediated proteolysis: interaction with AMBRA1 enhances interaction
CC       between PPP2CA and MYC. Mediates dephosphorylation of FOXO3; promoting
CC       its stabilization: interaction with AMBRA1 enhances interaction between
CC       PPP2CA and FOXO3 (By similarity). Catalyzes dephosphorylation of the
CC       pyrin domain of NLRP3, promoting assembly of the NLRP3 inflammasome (By
CC       similarity). Part of the striatin-interacting phosphatase and kinase
CC       (STRIPAK) complexes. STRIPAK complexes have critical roles in protein
CC       (de)phosphorylation and are regulators of multiple signaling pathways
CC       including Hippo, MAPK, nuclear receptor and cytoskeleton remodeling.
CC       Different types of STRIPAK complexes are involved in a variety of
CC       biological processes such as cell growth, differentiation, apoptosis,
CC       metabolism and immune regulation (By similarity).
CC       {ECO:0000250|UniProtKB:P63330, ECO:0000250|UniProtKB:P67775}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H2O + O-phospho-L-seryl-[protein] = L-seryl-[protein] +
CC         phosphate; Xref=Rhea:RHEA:20629, Rhea:RHEA-COMP:9863, Rhea:RHEA-
CC         COMP:11604, ChEBI:CHEBI:15377, ChEBI:CHEBI:29999, ChEBI:CHEBI:43474,
CC         ChEBI:CHEBI:83421; EC=3.1.3.16;
CC         Evidence={ECO:0000250|UniProtKB:P67775};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H2O + O-phospho-L-threonyl-[protein] = L-threonyl-[protein] +
CC         phosphate; Xref=Rhea:RHEA:47004, Rhea:RHEA-COMP:11060, Rhea:RHEA-
CC         COMP:11605, ChEBI:CHEBI:15377, ChEBI:CHEBI:30013, ChEBI:CHEBI:43474,
CC         ChEBI:CHEBI:61977; EC=3.1.3.16;
CC         Evidence={ECO:0000250|UniProtKB:P67775};
CC   -!- COFACTOR:
CC       Name=Mn(2+); Xref=ChEBI:CHEBI:29035;
CC         Evidence={ECO:0000250|UniProtKB:P67775};
CC       Note=Binds 2 manganese ions per subunit.
CC       {ECO:0000250|UniProtKB:P67775};
CC   -!- SUBUNIT: PP2A consists of a common heterodimeric core enzyme, composed
CC       of PPP2CA a 36 kDa catalytic subunit (subunit C) and PPP2R1A a 65 kDa
CC       constant regulatory subunit (PR65 or subunit A), that associates with a
CC       variety of regulatory subunits. Proteins that associate with the core
CC       dimer include three families of regulatory subunits B (the
CC       R2/B/PR55/B55, R3/B''/PR72/PR130/PR59 and R5/B'/B56 families), the 48
CC       kDa variable regulatory subunit, viral proteins, and cell signaling
CC       molecules. Interacts with the PP2A A subunit PPP2R1A (By similarity).
CC       Interacts (via C-terminus) with PTPA (By similarity). Interacts with
CC       NXN; the interaction is direct (By similarity). Interacts with KCTD20
CC       (By similarity). Interacts with BTBD10 (By similarity). Interacts with
CC       SGO1 and SGO2. Interacts with TP53. Interacts with AXIN1; the
CC       interaction dephosphorylates AXIN1. Interacts with PIM3; this
CC       interaction promotes dephosphorylation, ubiquitination and proteasomal
CC       degradation of PIM3. Interacts with RAF1. Interaction with IGBP1
CC       protects unassembled PPP2CA from degradative ubiquitination. Interacts
CC       with GSK3B (via C2 domain). Interacts with MFHAS1; retains PPP2CA into
CC       the cytoplasm and excludes it from the nucleus. Interacts with
CC       PABIR1/FAM122A. Interacts with ADCY8; interaction is phosphatase
CC       activity-dependent; antagonizes interaction between ADCY8 and
CC       calmodulin. Interacts with CRTC3 (when phosphorylated at 'Ser-391').
CC       Interacts with SPRY2; the interaction is inhibited by TESK1 interaction
CC       with SPRY2, possibly by vesicular sequestration of SPRY2. Interacts
CC       with TRAF3IP3. Interacts with AMBRA1 (via PxP motifs); enhancing
CC       interaction between PPP2CA and MYC or FOXO3. Forms a complex with
CC       AMBRA1 and BECN1; AMBRA1 and BECN1 components of the complex regulate
CC       MYC stability via different pathways (By similarity). Part of the core
CC       of STRIPAK complexes composed of PP2A catalytic and scaffolding
CC       subunits, the striatins (PP2A regulatory subunits), the striatin-
CC       associated proteins MOB4, STRIP1 and STRIP2, PDCD10 and members of the
CC       STE20 kinases, such as STK24 and STK26 (By similarity).
CC       {ECO:0000250|UniProtKB:P63330, ECO:0000250|UniProtKB:P67775}.
CC   -!- INTERACTION:
CC       P63331; P47942: Dpysl2; NbExp=2; IntAct=EBI-7050205, EBI-917570;
CC       P63331; P39687: ANP32A; Xeno; NbExp=2; IntAct=EBI-7050205, EBI-359234;
CC       P63331; O75663: TIPRL; Xeno; NbExp=3; IntAct=EBI-7050205, EBI-1054735;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250|UniProtKB:P67775}. Nucleus
CC       {ECO:0000250|UniProtKB:P67775}. Chromosome, centromere
CC       {ECO:0000250|UniProtKB:P67775}. Cytoplasm, cytoskeleton, spindle pole
CC       {ECO:0000250|UniProtKB:P67775}. Note=In prometaphase cells, but not in
CC       anaphase cells, localizes at centromeres. During mitosis, also found at
CC       spindle poles (By similarity). Centromeric localization requires the
CC       presence of SGO2 (By similarity). {ECO:0000250|UniProtKB:P63330,
CC       ECO:0000250|UniProtKB:P67775}.
CC   -!- PTM: Reversibly methyl esterified on Leu-309 by leucine carboxyl
CC       methyltransferase 1 (Lcmt1) and protein phosphatase methylesterase 1
CC       (Ppme1). Carboxyl methylation influences the affinity of the catalytic
CC       subunit for the different regulatory subunits, thereby modulating the
CC       PP2A holoenzyme's substrate specificity, enzyme activity and cellular
CC       localization (By similarity). {ECO:0000250|UniProtKB:P67774}.
CC   -!- PTM: Phosphorylation of either threonine (by autophosphorylation-
CC       activated protein kinase) or tyrosine results in inactivation of the
CC       phosphatase. Auto-dephosphorylation has been suggested as a mechanism
CC       for reactivation (By similarity). {ECO:0000250|UniProtKB:P67774}.
CC   -!- PTM: Polyubiquitinated, leading to its degradation by the proteasome.
CC       {ECO:0000250|UniProtKB:P67775}.
CC   -!- SIMILARITY: Belongs to the PPP phosphatase family. PP-1 subfamily.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; X16043; CAA34166.1; -; mRNA.
DR   EMBL; X14159; CAB42983.1; -; mRNA.
DR   EMBL; M33114; AAA41904.1; -; mRNA.
DR   EMBL; BC070914; AAH70914.1; -; mRNA.
DR   EMBL; BC072531; AAH72531.1; -; mRNA.
DR   PIR; S06592; PART2A.
DR   RefSeq; NP_058735.1; NM_017039.2.
DR   RefSeq; XP_008772116.1; XM_008773894.2.
DR   AlphaFoldDB; P63331; -.
DR   SMR; P63331; -.
DR   BioGRID; 246804; 10.
DR   CORUM; P63331; -.
DR   IntAct; P63331; 9.
DR   MINT; P63331; -.
DR   STRING; 10116.ENSRNOP00000007621; -.
DR   iPTMnet; P63331; -.
DR   PhosphoSitePlus; P63331; -.
DR   SwissPalm; P63331; -.
DR   jPOST; P63331; -.
DR   PaxDb; 10116-ENSRNOP00000007621; -.
DR   Ensembl; ENSRNOT00000007621.6; ENSRNOP00000007621.3; ENSRNOG00000005389.6.
DR   Ensembl; ENSRNOT00055008257; ENSRNOP00055006227; ENSRNOG00055005151.
DR   Ensembl; ENSRNOT00060044379; ENSRNOP00060036781; ENSRNOG00060025630.
DR   Ensembl; ENSRNOT00065007998; ENSRNOP00065005585; ENSRNOG00065005401.
DR   GeneID; 24672; -.
DR   KEGG; rno:24672; -.
DR   UCSC; RGD:3380; rat.
DR   AGR; RGD:3380; -.
DR   CTD; 5515; -.
DR   RGD; 3380; Ppp2ca.
DR   eggNOG; KOG0371; Eukaryota.
DR   GeneTree; ENSGT00550000074618; -.
DR   HOGENOM; CLU_004962_0_5_1; -.
DR   InParanoid; P63331; -.
DR   OMA; CMKVRYP; -.
DR   OrthoDB; 19833at2759; -.
DR   PhylomeDB; P63331; -.
DR   TreeFam; TF105559; -.
DR   Reactome; R-RNO-113501; Inhibition of replication initiation of damaged DNA by RB1/E2F1.
DR   Reactome; R-RNO-1295596; Spry regulation of FGF signaling.
DR   Reactome; R-RNO-141444; Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal.
DR   Reactome; R-RNO-180024; DARPP-32 events.
DR   Reactome; R-RNO-195253; Degradation of beta-catenin by the destruction complex.
DR   Reactome; R-RNO-196299; Beta-catenin phosphorylation cascade.
DR   Reactome; R-RNO-198753; ERK/MAPK targets.
DR   Reactome; R-RNO-202670; ERKs are inactivated.
DR   Reactome; R-RNO-2467813; Separation of Sister Chromatids.
DR   Reactome; R-RNO-2500257; Resolution of Sister Chromatid Cohesion.
DR   Reactome; R-RNO-2995383; Initiation of Nuclear Envelope (NE) Reformation.
DR   Reactome; R-RNO-389513; CTLA4 inhibitory signaling.
DR   Reactome; R-RNO-432142; Platelet sensitization by LDL.
DR   Reactome; R-RNO-4641262; Disassembly of the destruction complex and recruitment of AXIN to the membrane.
DR   Reactome; R-RNO-5663220; RHO GTPases Activate Formins.
DR   Reactome; R-RNO-5673000; RAF activation.
DR   Reactome; R-RNO-5675221; Negative regulation of MAPK pathway.
DR   Reactome; R-RNO-6804757; Regulation of TP53 Degradation.
DR   Reactome; R-RNO-6811558; PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling.
DR   Reactome; R-RNO-68877; Mitotic Prometaphase.
DR   Reactome; R-RNO-69231; Cyclin D associated events in G1.
DR   Reactome; R-RNO-69273; Cyclin A/B1/B2 associated events during G2/M transition.
DR   Reactome; R-RNO-9648025; EML4 and NUDC in mitotic spindle formation.
DR   Reactome; R-RNO-975957; Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC).
DR   Reactome; R-RNO-9833482; PKR-mediated signaling.
DR   PRO; PR:P63331; -.
DR   Proteomes; UP000002494; Chromosome 10.
DR   Bgee; ENSRNOG00000005389; Expressed in frontal cortex and 18 other cell types or tissues.
DR   GO; GO:0000775; C:chromosome, centromeric region; ISO:RGD.
DR   GO; GO:0005737; C:cytoplasm; ISO:RGD.
DR   GO; GO:0005829; C:cytosol; ISO:RGD.
DR   GO; GO:0090443; C:FAR/SIN/STRIPAK complex; ISO:RGD.
DR   GO; GO:0045121; C:membrane raft; ISS:UniProtKB.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0005886; C:plasma membrane; ISO:RGD.
DR   GO; GO:0000159; C:protein phosphatase type 2A complex; IMP:MGI.
DR   GO; GO:0008287; C:protein serine/threonine phosphatase complex; ISO:RGD.
DR   GO; GO:0000922; C:spindle pole; IEA:UniProtKB-SubCell.
DR   GO; GO:0045202; C:synapse; ISO:RGD.
DR   GO; GO:0043195; C:terminal bouton; IDA:RGD.
DR   GO; GO:0031698; F:beta-2 adrenergic receptor binding; IPI:ARUK-UCL.
DR   GO; GO:0019899; F:enzyme binding; IPI:RGD.
DR   GO; GO:0050811; F:GABA receptor binding; ISO:RGD.
DR   GO; GO:0042802; F:identical protein binding; IMP:MGI.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0017018; F:myosin phosphatase activity; IEA:UniProtKB-EC.
DR   GO; GO:1990405; F:protein antigen binding; IPI:RGD.
DR   GO; GO:0019904; F:protein domain specific binding; IDA:RGD.
DR   GO; GO:0046982; F:protein heterodimerization activity; ISS:UniProtKB.
DR   GO; GO:0043422; F:protein kinase B binding; IPI:RGD.
DR   GO; GO:0019901; F:protein kinase binding; IDA:RGD.
DR   GO; GO:0051721; F:protein phosphatase 2A binding; IDA:RGD.
DR   GO; GO:0019903; F:protein phosphatase binding; IPI:RGD.
DR   GO; GO:0004722; F:protein serine/threonine phosphatase activity; IDA:RGD.
DR   GO; GO:0004725; F:protein tyrosine phosphatase activity; ISO:RGD.
DR   GO; GO:0044877; F:protein-containing complex binding; IPI:RGD.
DR   GO; GO:0048156; F:tau protein binding; IPI:RGD.
DR   GO; GO:0044325; F:transmembrane transporter binding; IPI:RGD.
DR   GO; GO:0003231; P:cardiac ventricle development; IEP:RGD.
DR   GO; GO:0071277; P:cellular response to calcium ion; IEP:RGD.
DR   GO; GO:0071345; P:cellular response to cytokine stimulus; IEP:RGD.
DR   GO; GO:0071361; P:cellular response to ethanol; IEP:RGD.
DR   GO; GO:0071372; P:cellular response to follicle-stimulating hormone stimulus; IEP:RGD.
DR   GO; GO:0071333; P:cellular response to glucose stimulus; IMP:RGD.
DR   GO; GO:0032869; P:cellular response to insulin stimulus; IEP:RGD.
DR   GO; GO:0071383; P:cellular response to steroid hormone stimulus; IEP:RGD.
DR   GO; GO:0007507; P:heart development; IEP:RGD.
DR   GO; GO:0051321; P:meiotic cell cycle; IEA:UniProtKB-KW.
DR   GO; GO:0007498; P:mesoderm development; ISO:RGD.
DR   GO; GO:0000278; P:mitotic cell cycle; IBA:GO_Central.
DR   GO; GO:0010719; P:negative regulation of epithelial to mesenchymal transition; ISO:RGD.
DR   GO; GO:1904539; P:negative regulation of glycolytic process through fructose-6-phosphate; ISO:RGD.
DR   GO; GO:0035331; P:negative regulation of hippo signaling; ISS:UniProtKB.
DR   GO; GO:0051898; P:negative regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction; ISS:UniProtKB.
DR   GO; GO:0042308; P:negative regulation of protein import into nucleus; IMP:RGD.
DR   GO; GO:0001933; P:negative regulation of protein phosphorylation; IMP:RGD.
DR   GO; GO:0000122; P:negative regulation of transcription by RNA polymerase II; IMP:RGD.
DR   GO; GO:0043065; P:positive regulation of apoptotic process; IMP:RGD.
DR   GO; GO:1904528; P:positive regulation of microtubule binding; IMP:ARUK-UCL.
DR   GO; GO:1900227; P:positive regulation of NLRP3 inflammasome complex assembly; ISS:UniProtKB.
DR   GO; GO:0035307; P:positive regulation of protein dephosphorylation; IDA:RGD.
DR   GO; GO:2000045; P:regulation of G1/S transition of mitotic cell cycle; ISO:RGD.
DR   GO; GO:0031952; P:regulation of protein autophosphorylation; IMP:MGI.
DR   GO; GO:0042176; P:regulation of protein catabolic process; IMP:MGI.
DR   GO; GO:0001932; P:regulation of protein phosphorylation; IMP:MGI.
DR   GO; GO:0010469; P:regulation of signaling receptor activity; IMP:MGI.
DR   GO; GO:0010288; P:response to lead ion; IDA:ARUK-UCL.
DR   GO; GO:0043029; P:T cell homeostasis; ISS:UniProtKB.
DR   CDD; cd07415; MPP_PP2A_PP4_PP6; 1.
DR   Gene3D; 3.60.21.10; -; 1.
DR   InterPro; IPR004843; Calcineurin-like_PHP_ApaH.
DR   InterPro; IPR029052; Metallo-depent_PP-like.
DR   InterPro; IPR047129; PPA2-like.
DR   InterPro; IPR006186; Ser/Thr-sp_prot-phosphatase.
DR   PANTHER; PTHR45619; SERINE/THREONINE-PROTEIN PHOSPHATASE PP2A-RELATED; 1.
DR   PANTHER; PTHR45619:SF42; SERINE_THREONINE-PROTEIN PHOSPHATASE 2A CATALYTIC SUBUNIT ALPHA ISOFORM; 1.
DR   Pfam; PF00149; Metallophos; 1.
DR   PRINTS; PR00114; STPHPHTASE.
DR   SMART; SM00156; PP2Ac; 1.
DR   SUPFAM; SSF56300; Metallo-dependent phosphatases; 1.
DR   PROSITE; PS00125; SER_THR_PHOSPHATASE; 1.
PE   1: Evidence at protein level;
KW   Centromere; Chromosome; Cytoplasm; Cytoskeleton; Hydrolase; Manganese;
KW   Meiosis; Metal-binding; Methylation; Nucleus; Phosphoprotein;
KW   Protein phosphatase; Reference proteome; Ubl conjugation.
FT   CHAIN           1..309
FT                   /note="Serine/threonine-protein phosphatase 2A catalytic
FT                   subunit alpha isoform"
FT                   /id="PRO_0000058843"
FT   ACT_SITE        118
FT                   /note="Proton donor"
FT                   /evidence="ECO:0000250|UniProtKB:P36873"
FT   BINDING         57
FT                   /ligand="Mn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29035"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000250|UniProtKB:P67775"
FT   BINDING         59
FT                   /ligand="Mn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29035"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000250|UniProtKB:P67775"
FT   BINDING         85
FT                   /ligand="Mn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29035"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000250|UniProtKB:P67775"
FT   BINDING         85
FT                   /ligand="Mn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29035"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000250|UniProtKB:P67775"
FT   BINDING         117
FT                   /ligand="Mn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29035"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000250|UniProtKB:P67775"
FT   BINDING         167
FT                   /ligand="Mn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29035"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000250|UniProtKB:P67775"
FT   BINDING         241
FT                   /ligand="Mn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29035"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000250|UniProtKB:P67775"
FT   MOD_RES         307
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000250|UniProtKB:P67774"
FT   MOD_RES         309
FT                   /note="Leucine methyl ester"
FT                   /evidence="ECO:0000250|UniProtKB:P67774"
SQ   SEQUENCE   309 AA;  35608 MW;  8DC11276E6DF9E33 CRC64;
     MDEKLFTKEL DQWIEQLNEC KQLSESQVKS LCEKAKEILT KESNVQEVRC PVTVCGDVHG
     QFHDLMELFR IGGKSPDTNY LFMGDYVDRG YYSVETVTLL VALKVRYRER ITILRGNHES
     RQITQVYGFY DECLRKYGNA NVWKYFTDLF DYLPLTALVD GQIFCLHGGL SPSIDTLDHI
     RALDRLQEVP HEGPMCDLLW SDPDDRGGWG ISPRGAGYTF GQDISETFNH ANGLTLVSRA
     HQLVMEGYNW CHDRNVVTIF SAPNYCYRCG NQAAIMELDD TLKYSFLQFD PAPRRGEPHV
     TRRTPDYFL
//
